Showing results (1-10 of 80) with videos related to
Sort By:
Pageof 8
MMW Fortschritte Der Medizin|January 29, 2010
[The importance of therapeutic drug monitoring for psychotropic drugs]Thomas Messer, Max SchmaussPsychiatrische Praxis|December 13, 2006
[Augmentation strategies for therapy resistant depression - a review]Max Schmauss, Thomas MesserPsychiatrische Praxis|December 1, 2004
[Rehospitalization rates of newly diagnosed schizophrenic patients on atypical neuroleptic medication]Oliver Strasser, Max Schmauss, Thomas MesserCNS Drugs|January 18, 2005
Efficacy and tolerability of reboxetine in depressive patients treated in routine clinical practiceThomas Messer, Max Schmauss, Judith Lambert-BaumannPsychiatrische Praxis|December 1, 2004
[Determining serum concentrations of the modern antipsychotic quetiapin: clinical relevance in therapeutic drug monitoring]Oliver Köhnlein, Rita Lutz, Max Schmauss, et al.Psychiatrische Praxis|December 1, 2004
[Management of the atypical antipsychotic olanzapine in a clinical environment with particular regard to therapeutic drug monitoring (TDM) in a German State hospital]Rita Lutz, Oliver Köhnlein, Max Schmauss, et al.Psychiatrische Praxis|December 1, 2004
[Drug monitoring of antipsychotics and antidepressants during acute admission in a psychiatric state hospital in Germany]Michael Vogel, Oliver Köhnlein, Max Schmauss, et al.Psychiatrische Praxis|December 1, 2004
[German language skills among foreign psychiatric patients: influence on voluntariness and duration of hospital treatment]Nicole Künzler, Eva Garcia-Brand, Max Schmauss, et al.Psychiatrische Praxis|December 1, 2004
[Prevalence of mental disorders in the out-patient clinic for environmental diseases (Umweltmedizinische Ambulanz) in Augsburg central hospital]Lydia Teufel-Maier, Monika Schulze, Max Schmauss, et al.The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|March 12, 2010
Clinical use of aripiprazole in patients with schizophrenia: a real-life setting results from the German Postmarketing Surveillance StudyThomas Messer, Max Schmauss, Terez Spevakne-Goeroecs, et al.Pageof 8